Glucose, Lipid, and Blood Pressure Control in Australian Adults With Type 2 Diabetes
2005; American Diabetes Association; Volume: 28; Issue: 6 Linguagem: Inglês
10.2337/diacare.28.6.1490
ISSN1935-5548
AutoresT Kemp, Elizabeth Barr, Paul Zimmet, Adrian J. Cameron, Timothy A. Welborn, Stephen Colagiuri, Patrick Phillips, Jonathan E. Shaw,
Tópico(s)Diabetes Management and Research
ResumoThe risk of diabetes complications can be reduced by tight control of blood glucose (1), serum lipids (2), and blood pressure (3,4). However, evidence from a limited number of studies (5–9) indicates that many people with type 2 diabetes do not achieve recommended targets for these factors. We examined levels of glucose, lipid, and blood pressure control in participants with type 2 diabetes taking part in the national population-based Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) (10) conducted during 1999–2000. AusDiab was a national population-based survey of the general population and has been described in detail earlier (10). Diagnosis of diabetes was based on self-reported physician diagnosis of diabetes confirmed either by self-reported use of hypoglycemic drugs or results from a 75-g oral glucose tolerance test (11). Participants who started insulin treatment within 2 years of diagnosis were classified as having type 1 diabetes (if diabetes onset was at age ≥40 years; BMI also had to be <27 kg/m2). All other cases were classified as type 2 diabetes. Fasting (≥9 h) serum total cholesterol, LDL and HDL cholesterol, and triglycerides were measured (Olympus AU600 analyzer; Olympus Optical, Tokyo, Japan). Total glycated hemoglobin analysis used high-performance liquid chromatography (Bio-Rad Variant Hemoglobin Testing System; Bio-Rad, Hercules, CA) with standardized conversion to HbA1c values …
Referência(s)